Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms

Tuberculosis produces two clinical manifestations: active and latent (non-apparent) disease. The latter is estimated to affect one-third of the world population and constitutes a source of continued transmission should the disease emerge from its hidden state (reactivation). Methods to diagnose late...

Descrición completa

Detalles Bibliográficos

Principais autores:	Patrick Van Dijck, Jelmer Sjollema, Bruno P.A. Cammue, Katrien Lagrou, Judith Berman, Christophe d’Enfert, David R. Andes, Maiken C. Arendrup, Axel A. Brakhage, Richard Calderone, Emilia Cantón, Tom Coenye, Paul Cos, Leah E. Cowen, Mira Edgerton, Ana Espinel-Ingroff, Scott G. Filler, Mahmoud Ghannoum, Neil A.R. Gow, Hubertus Haas, Mary Ann Jabra-Rizk, Elizabeth M. Johnson, Shawn R. Lockhart, Jose L. Lopez-Ribot, Johan Maertens, Carol A. Munro, Jeniel E. Nett, Clarissa J. Nobile, Michael A. Pfaller, Gordon Ramage, Dominique Sanglard, Maurizio Sanguinetti, Isabel Spriet, Paul E. Verweij, Adilia Warris, Joost Wauters, Michael R. Yeaman, Sebastian A.J. Zaat, Karin Thevissen
Formato:	Artigo
Idioma:	Inglês
Publicado:	Shared Science Publishers OG 2018-06-01
Series:	Microbial Cell
Assuntos:	tuberculosis latent infection diagnosis proteomics transcriptomics point-of-care immune response
Acceso en liña:	http://microbialcell.com/researcharticles/uncovering-the-hidden-complexity-and-strategies-for-diagnosing-latent-tuberculosis/
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!